News
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...
New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...
The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
Using an AI-driven drug discovery process, the drug known as vorinostat was identified as a promising treatment for Rett ...
A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...
In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, ...
Scientists discovered a cancer-fighting compound in mold from ancient tombs, revealing a powerful new drug against leukemia.
The newly licensed drug, leniolisib, is the first targeted treatment for her condition, Activated PI3-kinase Delta Syndrome ...
DCC gives nod to amend Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Monday, July 7, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
11d
GlobalData on MSNVor Bio back from brink with autoimmune drug deal rising to $4bnEquipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.
(Reuters) -The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results